how to cite:
Soltany
S, Alavy Toussy
J , Malek
M, Hemmaty
H, Maghsoomi
Z. Effects of oral pentoxyphylline on the healing of foot ulcers in the diabetic patients. koomesh. 2024;16(1):e151274.
Abstract
Introduction: Diabetic foot ulcer is the complication of
diabetes that commonly led to lower limb amputation. Pentoxyphylline is one of
the systemic drugs suggested in the healing of different wounds. In the present
study, its effect on healing of the diabetic foot ulcer was evaluated. Materials and Methods: In a double blind randomized clinical trial,
patients with diabetic foot ulcer referred to diabetes clinic of Fatemieh
hospital, Semnan, Iran, evaluated. In one group oral Pentoxyphylline 400 mg,
three times a day and in the control group placebo prescribed. Reduction
of the wound size and the incidence of
complete wound healing considered as the indicators of wound healing. Results: From 110 patients enrolled in the study, 30
patients excluded because of unbearable dizziness, retinal hemorrhage, need to
debridement and loss to follow up. At the end, 80 patients in two groups (each
with 40 patients) evaluated. In Pentoxyphylline group, the percentage of wound
healing at the end of the first and second months was significantly higher. The
rate of complete wound healing was higher but not statistically significant. In
addition, the prevalence of nausea and dizziness in Pentoxyphylline group, was
significant. Conclusion: Pentoxyphylline
is effective in the healing of diabetic foot ulcer by decreasing the wound size
in patients without peripheral vascular diseases. However, because of the
probable adverse effects, it should used with caution.